Cancer News and Research

Latest Cancer News and Research

Regis to host one-day haircutting event in support of breast cancer research

This year, the American Cancer Society estimates over 230,000 new cases of invasive breast cancer will be diagnosed in women.

31 Aug 2011

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

Selecta Biosciences, Inc., a biopharmaceutical company developing an entirely new class of targeted vaccines and immunotherapies, today announced that Science Applications International Corporation (SAIC) has awarded Selecta a subcontract to develop a targeted synthetic vaccine particle product for malaria.

31 Aug 2011

Research shows numerous health benefits of Modified Citrus Pectin

New research published in the journal BMC Complementary and Alternative Medicine shows Modified Citrus Pectin (MCP) packs a powerful immune punch.

31 Aug 2011

Patients with sarcopenia more likely to have worse outcomes from melanoma

It's not how old but how frail patients are that can predict how well they will fare after a melanoma diagnosis. In fact, young patients in poor health may have worse outcomes than older patients in good shape.

31 Aug 2011

Patients with coronary artery disease more likely to have complications from orthopedic surgery

Thrombotic and bleeding events are complications that may occur after surgery. With the aging population in the western world, there are more patients undergoing orthopedic surgery than ever before. This makes understanding the risk of complications from orthopedic surgery exceedingly important. However, there is a lack of data investigating the incidence of thrombotic and bleeding complications in orthopedic surgery.

31 Aug 2011

Simple tips for children's shoe shopping

As parents and children begin the back to school shopping ritual that includes fashionable shoes, the Ontario Society of Chiropodists (OSC) stresses that fit is more important than looks. Well-fitting shoes reduce the incidence of foot and ankle injuries and encourages physical activity, helping to increase self esteem through sport.

31 Aug 2011

Positive results from Bionovo's Menerba tolerability trial on menopausal hot flashes

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.

31 Aug 2011

Enrollment commences in Adamis' APC-100 Phase 1/2a clinical prostate study

Adamis Pharmaceuticals Corporation announced today that it enrolled the first patient in its Phase 1/2a clinical prostate study. Adamis' drug, APC-100, will be used to treat men with castrate-resistant prostate cancer.

31 Aug 2011

Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

Aeterna Zentaris Inc. today announced favorable top-line results of its completed Phase 3 study with AEZS-130 as the first oral diagnostic test for Adult Growth Hormone Deficiency.

31 Aug 2011

Viewpoints: States' anti-abortion laws; unproven cancer therapy; paying for retirees' health benefits

Since last year, 13 states, including Kansas, have enacted laws banning insurance coverage of abortion in the health insurance exchanges created by the federal health care reform law. Some states have gone even further, aggressively restricting abortion coverage even in private insurance plans sold outside the exchanges. ... These cases, some of which are being appealed, are testing whether the antiabortion movement will get its way. It shouldn't.

31 Aug 2011

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

Barriers that hinder young African-American, Hispanic and poor women from completing a series of three vaccinations to prevent human papillomavirus infection (HPV) also leave them at higher risk for cervical cancer and death.

30 Aug 2011

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Aeterna Zentaris Inc. today announced that a poster on its novel orally active anticancer Erk inhibitor, which includes AEZS-131, was presented at the 242nd American Chemical Society National Meeting held at the Colorado Convention Center in Denver, Colorado.

30 Aug 2011

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

Radiation can make cancer cells resistant to radio- and chemotherapy. University of Oslo researchers have now figured out how resistance can be switched on and off.

30 Aug 2011

Invacare announces winners of Real Life campaign contest

Invacare Corporation, the global leader in the manufacture and distribution of home and long-term care medical products, today announced the winners of its Real Life campaign contest.

30 Aug 2011

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.

30 Aug 2011

ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.

30 Aug 2011

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

Two scientists developed a new drug that helped pioneer the era of "personalized medicine" for cancer patients, an approach in which one-size-fits-all drugs yield to medicines customized to the genetic endowment of individual patients. Another scientist invented today's predominant technology for genetic sequencing, deciphering the genetic blueprint in the DNA that makes up the genes of living things.

30 Aug 2011

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

DiagnoCure, Inc., a life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.

30 Aug 2011

An advance toward using stem cells in 'regenerative medicine'

With stem cells so fickle and indecisive that they make Shakespeare's Hamlet pale by comparison, scientists today described an advance in encouraging stem cells to make decisions about their fate.

30 Aug 2011

RaySearch Laboratories reports net sales of SEK 47.6 M for January 1 - June 30, 2011

RaySearch Laboratories: JANUARY 1 - JUNE 30, 2011. Net sales for the period totaled SEK 47.6 M.

30 Aug 2011

Cancer News and Research

Latest Cancer News and Research

Regis to host one-day haircutting event in support of breast cancer research

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

Research shows numerous health benefits of Modified Citrus Pectin

Patients with sarcopenia more likely to have worse outcomes from melanoma

Patients with coronary artery disease more likely to have complications from orthopedic surgery

Simple tips for children's shoe shopping

Positive results from Bionovo's Menerba tolerability trial on menopausal hot flashes

Enrollment commences in Adamis' APC-100 Phase 1/2a clinical prostate study

Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

Viewpoints: States' anti-abortion laws; unproven cancer therapy; paying for retirees' health benefits

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

Invacare announces winners of Real Life campaign contest

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

An advance toward using stem cells in 'regenerative medicine'

RaySearch Laboratories reports net sales of SEK 47.6 M for January 1 - June 30, 2011

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in